• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭的非药物治疗——从体力活动到电疗法:文献综述

Non-Pharmacological Treatment of Heart Failure-From Physical Activity to Electrical Therapies: A Literature Review.

作者信息

Scarà Antonio, Palamà Zefferino, Robles Antonio Gianluca, Dei Lorenzo-Lupo, Borrelli Alessio, Zanin Federico, Pignalosa Leonardo, Romano Silvio, Sciarra Luigi

机构信息

San Carlo di Nancy Hospital-GVM, 00165 Roma, Italy.

Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

出版信息

J Cardiovasc Dev Dis. 2024 Apr 17;11(4):122. doi: 10.3390/jcdd11040122.

DOI:10.3390/jcdd11040122
PMID:38667740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11050051/
Abstract

Heart failure (HF) represents a significant global health challenge that is still responsible for increasing morbidity and mortality despite advancements in pharmacological treatments. This review investigates the effectiveness of non-pharmacological interventions in the management of HF, examining lifestyle measures, physical activity, and the role of some electrical therapies such as catheter ablation, cardiac resynchronization therapy (CRT), and cardiac contractility modulation (CCM). Structured exercise training is a cornerstone in this field, demonstrating terrific improvements in functional status, quality of life, and mortality risk reduction, particularly in patients with HF with reduced ejection fraction (HFrEF). Catheter ablation for atrial fibrillation, premature ventricular beats, and ventricular tachycardia aids in improving left ventricular function by reducing arrhythmic burden. CRT remains a key intervention for selected HF patients, helping achieve left ventricular reverse remodeling and improving symptoms. Additionally, the emerging therapy of CCM provides a novel opportunity for patients who do not meet CRT criteria or are non-responders. Integrating non-pharmacological interventions such as digital health alongside specific medications is key for optimizing outcomes in HF management. It is imperative to tailor approaches to individual patients in this diverse patient population to maximize benefits. Further research is warranted to improve treatment strategies and enhance patient outcomes in HF management.

摘要

心力衰竭(HF)是一项重大的全球健康挑战,尽管药物治疗取得了进展,但它仍然导致发病率和死亡率不断上升。本综述探讨了非药物干预在HF管理中的有效性,研究了生活方式措施、体育活动以及一些电疗法(如导管消融、心脏再同步治疗(CRT)和心脏收缩力调制(CCM))的作用。结构化运动训练是该领域的基石,在功能状态、生活质量和降低死亡风险方面显示出显著改善,尤其是在射血分数降低的心力衰竭(HFrEF)患者中。针对心房颤动、室性早搏和室性心动过速的导管消融通过减轻心律失常负担有助于改善左心室功能。CRT仍然是选定HF患者的关键干预措施,有助于实现左心室逆向重构并改善症状。此外,新兴的CCM疗法为不符合CRT标准或无反应的患者提供了新的机会。将数字健康等非药物干预与特定药物相结合是优化HF管理结果的关键。在这个多样化的患者群体中,根据个体患者量身定制方法以最大化益处至关重要。有必要进行进一步研究以改善治疗策略并提高HF管理中的患者结局。

相似文献

1
Non-Pharmacological Treatment of Heart Failure-From Physical Activity to Electrical Therapies: A Literature Review.心力衰竭的非药物治疗——从体力活动到电疗法:文献综述
J Cardiovasc Dev Dis. 2024 Apr 17;11(4):122. doi: 10.3390/jcdd11040122.
2
Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.双心室起搏(心脏再同步治疗):基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(13):1-60. Epub 2005 Sep 1.
3
Contemporary management of heart failure patients with reduced ejection fraction: the role of implantable devices and catheter ablation.射血分数降低的心力衰竭患者的当代管理:植入式装置和导管消融的作用。
Rev Cardiovasc Med. 2021 Jun 30;22(2):415-428. doi: 10.31083/j.rcm2202047.
4
Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.心脏收缩力调节:在射血分数降低和永久性心房颤动的心力衰竭患者中的初步经验。
Europace. 2014 Aug;16(8):1205-9. doi: 10.1093/europace/euu050. Epub 2014 Apr 4.
5
Advanced electrophysiologic mapping systems: an evidence-based analysis.先进的电生理标测系统:基于证据的分析
Ont Health Technol Assess Ser. 2006;6(8):1-101. Epub 2006 Mar 1.
6
Prognostic significance of diastolic dysfunction in patients with systolic dysfunction undergoing atrial fibrillation ablation.收缩功能障碍患者行房颤消融时舒张功能障碍的预后意义
Int J Cardiol Heart Vasc. 2022 Jul 4;41:101079. doi: 10.1016/j.ijcha.2022.101079. eCollection 2022 Aug.
7
Cardiac contractility modulation: a novel approach for the treatment of heart failure.心脏收缩力调制:一种治疗心力衰竭的新方法。
Heart Fail Rev. 2016 Nov;21(6):645-660. doi: 10.1007/s10741-016-9571-6.
8
Atrioventricular Nodal Catheter Ablation in Atrial Fibrillation Complicating Congestive Heart Failure.充血性心力衰竭合并心房颤动时的房室结导管消融术
J Atr Fibrillation. 2018 Jun 30;11(1):1813. doi: 10.4022/jafib.1813. eCollection 2018 Jun-Jul.
9
Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.用于治疗心律失常的植入式心脏复律除颤器和用于治疗心力衰竭的心脏再同步治疗:系统评价与经济学评估
Health Technol Assess. 2014 Aug;18(56):1-560. doi: 10.3310/hta18560.
10
Cardiac Contractility Monitoring: an Important Therapy in the Treatment of Advanced Heart Failure.心肌收缩力监测:治疗晚期心力衰竭的重要疗法。
Curr Cardiol Rep. 2020 Jul 9;22(9):81. doi: 10.1007/s11886-020-01330-0.

引用本文的文献

1
Chronic Heart Failure Rehabilitation: Diaphragm Training Needs More Attention.慢性心力衰竭康复:膈肌训练需要更多关注。
J Clin Med. 2025 Aug 8;14(16):5624. doi: 10.3390/jcm14165624.
2
Stressful Life Events and Heart Failure: A Mixed-Method Study to Analyze the Patient's Perspective.应激性生活事件与心力衰竭:一项分析患者观点的混合方法研究。
Cardiol Ther. 2025 Jun;14(2):199-217. doi: 10.1007/s40119-025-00406-8. Epub 2025 Apr 17.
3
Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system.

本文引用的文献

1
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
2
Long-term outcomes from upgrade to cardiac resynchronisation therapy in ischaemic versus non-ischaemic heart disease.缺血性与非缺血性心脏病患者心脏再同步治疗升级的长期结局。
Acta Cardiol. 2024 May;79(3):327-337. doi: 10.1080/00015385.2023.2277624. Epub 2023 Nov 14.
3
胺碘酮不同给药途径的不良事件:一项基于美国食品药品监督管理局不良事件报告系统的药物警戒研究。
Front Pharmacol. 2025 Jan 27;16:1517616. doi: 10.3389/fphar.2025.1517616. eCollection 2025.
4
Allostatic load modelling, lifestyle and cardiological risk factor: evidence for integrating patient profiling in the optimisation of pharmacological therapies during follow-ups in hospital setting - PLAY-UP cohort study protocol.应激适应负荷建模、生活方式和心血管风险因素:在医院环境下随访期间优化药物治疗中整合患者特征分析的证据 - PLAY-UP 队列研究方案。
BMJ Open. 2024 Nov 20;14(11):e082459. doi: 10.1136/bmjopen-2023-082459.
5
CTRP6-mediated cardiac protection in heart failure via the AMPK/SIRT1/PGC-1α signalling pathway.CTRP6 通过 AMPK/SIRT1/PGC-1α 信号通路介导心力衰竭中的心脏保护作用。
Exp Physiol. 2024 Dec;109(12):2031-2045. doi: 10.1113/EP092036. Epub 2024 Sep 26.
Cardiac resynchronization therapy non-responder to responder conversion rate in the MORE-CRT MPP trial.
MORE-CRT MPP 试验中心力再同步治疗无反应者到有反应者的转化率。
Europace. 2023 Oct 5;25(10). doi: 10.1093/europace/euad294.
4
His-Purkinje Conduction System Pacing Optimized Trial of Cardiac Resynchronization Therapy vs Biventricular Pacing: HOT-CRT Clinical Trial.希氏-浦肯野系统起搏优化心脏再同步治疗与双心室起搏的临床试验:HOT-CRT 临床试验。
JACC Clin Electrophysiol. 2023 Dec;9(12):2628-2638. doi: 10.1016/j.jacep.2023.08.003. Epub 2023 Sep 13.
5
Different Continuous Training Intensities Improve Echocardiographic Parameters, Quality of Life, and Functional Capacity in Heart Failure Patients with Reduced Ejection Fraction.不同的持续训练强度可改善射血分数降低的心力衰竭患者的超声心动图参数、生活质量和功能能力。
Int J Gen Med. 2023 Aug 30;16:3933-3945. doi: 10.2147/IJGM.S420933. eCollection 2023.
6
Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial.心力衰竭患者的适应性与传统心脏再同步治疗(AdaptResponse):一项全球前瞻性随机对照试验。
Lancet. 2023 Sep 30;402(10408):1147-1157. doi: 10.1016/S0140-6736(23)00912-1. Epub 2023 Aug 24.
7
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.《2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南》2023年聚焦更新
Eur Heart J. 2023 Oct 1;44(37):3627-3639. doi: 10.1093/eurheartj/ehad195.
8
Patient Perspectives on Digital Interventions to Manage Heart Failure Medications: The VITAL-HF Pilot.患者对管理心力衰竭药物的数字干预措施的看法:VITAL-HF试点项目
J Clin Med. 2023 Jul 14;12(14):4676. doi: 10.3390/jcm12144676.
9
Remote monitoring titration clinic to implement guideline-directed therapy for heart failure patients with reduced ejection fraction: a pilot quality-improvement intervention.远程监测滴定诊所对射血分数降低的心力衰竭患者实施指南导向治疗:一项试点质量改进干预措施。
Front Cardiovasc Med. 2023 Jun 19;10:1202615. doi: 10.3389/fcvm.2023.1202615. eCollection 2023.
10
Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial.慢性心力衰竭患者肺动脉压的远程血流动力学监测(MONITOR-HF):一项随机临床试验。
Lancet. 2023 Jun 24;401(10394):2113-2123. doi: 10.1016/S0140-6736(23)00923-6. Epub 2023 May 20.